Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Sirion

  • Multiplexed Drug Assessment in 3D
    ... harboring the secreted NanoLuc luciferase (HCT-116-NanoLuc) and mouse fibroblasts harboring the red fluorescence protein (NIH3T3-RFP; cell lines were generated by Sirion Biotech). ...
    12-1-2012
  • Overcoming Drawbacks of Gene Silencing with RNAi
    Sirion Biotech has developed technologies that help overcome the drawbacks of RNA ... Sirion has developed RNAiONE(tm) for fast and reliable identification of the most ...
    12-1-2012
  • Helmholtz Zentrum München and Sirion Biotech Partner to Study...
    Helmholtz Zentrum München and Sirion Biotech are allying to develop new therapeutic ... Helmholtz Zentrum München and Sirion Biotech seek to optimize the use of lentiviruses as ...
    3-29-2010
  • Alcon Buys Ophthalmic Pharmaceutical Assets from Sirion
    Alcon is purchasing U.S. rights for two FDA-approved topical eyecare products from Sirion ... "The acquisition of these products from Sirion is part of our business-development ...
    1-19-2010
  • Into the Looking Glass-The Future of Ocular Therapeutics
    ... derivatives (Phase III ST603 from Sirion Therapeutics and Phase III Nova22007 from ... Other compounds in development are Phase III Durezol (Senju Pharmaceutical and Sirion ...
    6-10-2009
  • Enhancing PCR for Diagnostic Applications
    ... upcoming conference in Germany will be Christian Thirion, Ph.D., CSO, Sirion Biotech. Dr. ... From this work, the Sirion researchers concluded that TNF- α specifically acts on ...
    1-15-2009

  • Journal Articles

  • Durezol ® (Difluprednate Ophthalmic Emulsion 0.05%) Compared...
    C. Stephen Foster, Robert DaVanzo, Thomas E. Flynn, Kimberly McLeod, Roger Vogel, R. Steve Crockett
    Journal of Ocular Pharmacology and Therapeutics
    registration: Trial NCT00501579 was registered at the National Institutes of Health Registry in July 2007 (http://clinicaltrials.gov/ct2/show/NCT00501579?term=sirion&rank=4).

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll